SRDX : Summary for Surmodics, Inc. - Yahoo Finance

U.S. Markets open in 3 hrs 23 mins

Surmodics, Inc. (SRDX)


NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
25.05+0.10 (+0.40%)
At close: 4:00PM EST
People also watch
VASCTECHSPNCICUIVIVO
Interactive chart
  • 1d
  • 5d
  • 1m
  • 6m
  • YTD
  • 1y
  • 2y
  • 5y
  • 10y
  • Max
1d
Previous Close24.95
Open24.85
Bid0.00 x
Ask0.00 x
Day's Range24.85 - 25.20
52 Week Range17.45 - 30.75
Volume25,328
Avg. Volume54,286
Market Cap332.33M
Beta0.68
PE Ratio (TTM)34.32
EPS (TTM)N/A
Earnings DateN/A
Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
Trade prices are not sourced from all markets
  • Capital Cube12 days ago

    SurModics, Inc. :SRDX-US: Earnings Analysis: Q1, 2017 By the Numbers : February 15, 2017

    Categories: Yahoo Finance Get free summary analysis SurModics, Inc. reports financial results for the quarter ended December 31, 2016. We analyze the earnings along side the following peers of SurModics, Inc. – Thermo Fisher Scientific Inc., Abbott Laboratories, pSivida Corp., Johnson & Johnson and PerkinElmer, Inc. (TMO-US, ABT-US, PSDV-US, JNJ-US and PKI-US) that have also reported for this ... Read more (Read more...)

  • Business Wire18 days ago

    Surmodics Announces 2017 Annual Shareholders Meeting

    Surmodics, Inc. , a leading provider of medical device and in vitro diagnostic technologies to the healthcare industry, today announced that its virtual Annual Meeting of Shareholders will be held on Tuesday, February 14, at 4:00 p.m.

  • SurModics (SRDX) Beats Earnings & Revenue Estimates in Q1
    Zacks21 days ago

    SurModics (SRDX) Beats Earnings & Revenue Estimates in Q1

    Surmodics, Inc. (SRDX) reported earnings of 19 cents per share in the first-quarter of fiscal 2017 surpassing the Zacks Consensus Estimate of 9 cents.